Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines.

International journal of molecular sciences·2020
Same author

Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.

American journal of therapeutics·2020
Same author

Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma.

Journal of community hospital internal medicine perspectives·2019
Same author

Digging deep into diabetes: achieving better glycemic control in diabetic patients in a resident-run clinic.

Journal of community hospital internal medicine perspectives·2019
Same author

An educational intervention to increase awareness reduces unnecessary laboratory testing in an internal medicine resident-run clinic.

Journal of community hospital internal medicine perspectives·2017
Same author

Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.

Oncotarget·2016

Related Experiment Video

Updated: May 20, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Constipation in Clostridium difficile infection.

Hameem I Kawsar1, K V Gopal, Jamila Shahnewaz

  • 1Department of Medicine, Fairview Hospital, Cleveland, Ohio, USA.

BMJ Case Reports
|July 5, 2012
PubMed
Summary
This summary is machine-generated.

Clostridium difficile infection can cause severe respiratory distress and multi-organ failure, even without typical gastrointestinal symptoms. Early diagnosis and treatment are crucial for patients with worsening respiratory symptoms and elevated white blood cell counts.

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Related Experiment Videos

Last Updated: May 20, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Gastroenterology

Background:

  • Clostridium difficile infection (CDI) is a significant cause of healthcare-associated diarrhea.
  • Atypical presentations of CDI, particularly respiratory involvement, are less commonly recognized.

Observation:

  • A patient presented with progressive respiratory distress and cough following a viral-like illness.
  • Despite initial treatment with antibiotics and steroids, the patient's condition worsened with increasing leucocyte count.
  • Stool analysis confirmed Clostridium difficile toxin, and abdominal imaging revealed cecal and proximal colon distension.

Findings:

  • The patient was diagnosed with Clostridium difficile infection presenting atypically with respiratory symptoms.
  • Treatment with metronidazole, vancomycin, and intravenous immunoglobulin was initiated.
  • Despite aggressive management, the patient developed multi-organ failure and succumbed to the illness.

Implications:

  • This case highlights the importance of considering Clostridium difficile infection in patients with unexplained respiratory deterioration, even in the absence of diarrhea.
  • Atypical presentations of CDI can mimic other severe conditions, necessitating a high index of suspicion and prompt diagnostic testing.
  • Understanding the spectrum of CDI manifestations is critical for timely and effective patient management in critical care settings.